Published in

BioMed Central, Genome Medicine, 1(12), 2020

DOI: 10.1186/s13073-020-00792-9

Links

Tools

Export citation

Search in Google Scholar

Genomics in the era of COVID-19: ethical implications for clinical practice and public health

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Abstract Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications—both potential benefits and harms—of genomics for clinical practice and public health in the era of COVID-19.